Skip to main content
Clinical Trials/NCT02242500
NCT02242500
Completed
Phase 4

Phase IV Study of Coronally Advanced Flap With or Without Porcine Collagen Matrix for Treatment of Gingival Recession: a Randomized Controlled Clinical Trial

Enilson Antonio Sallum1 site in 1 country40 target enrollmentDecember 2010

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Gingival Recession
Sponsor
Enilson Antonio Sallum
Enrollment
40
Locations
1
Primary Endpoint
Recession Reduction
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to compare the clinical outcomes after coronally advanced flap technique (CAF) associated or not to a porcine collagen matrix graft (CM) in the treatment of single gingival recessions. For this blinded randomized controlled clinical trial, 40 patients with Miller Class I or II gingival recession ≥ 2 mm in canines or premolars will selected and randomly assigned to receive either CAF or CAF+CM. The clinical parameters evaluated will be probing depth, clinical attachment level, gingival recession height, height and thickness of keratinized tissue. Clinical measurements will be taken at baseline and 45 days, 2, 3 and 6 months after surgery.

Registry
clinicaltrials.gov
Start Date
December 2010
End Date
October 2013
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Enilson Antonio Sallum
Responsible Party
Sponsor Investigator
Principal Investigator

Enilson Antonio Sallum

Chair of the Department of Prosthodontics and Periodontics, Division of Periodontics, Piracicaba Dental School

University of Campinas, Brazil

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years.
  • Presence of at least one Class I or II Miller gingival recession ≥ 2 mm in maxillary canines or premolars with identifiable cementum-enamel junction (CEJ) and without deep non-carious cervical lesions (\< 0.5 mm): A + (Pini-Prato et al. 2010).
  • Aesthetic complaint and/or presence of dentin hypersensitivity to air stimulus.
  • Full-mouth visible plaque index ≤ 20% (Ainamo \& Bay 1975).
  • Full-mouth sulcus bleeding index ≤ 20% (Mühlemann \& Son 1971).

Exclusion Criteria

  • Pregnancy.
  • Presence of systemic disorders (diabetes, hypertension, heart disease or any other condition that could contraindicate periodontal surgery).
  • Use of medications (immunosuppressants, phenytoin or anything else that might affect mucosal healing and repair).
  • Previous periodontal surgery in the area.

Outcomes

Primary Outcomes

Recession Reduction

Time Frame: 6 months

Measured as a difference between gingival margin between gingival recession depth at baseline and gingival recession at 6 months follow-up.

Secondary Outcomes

  • Complete root coverage(6 months)

Study Sites (1)

Loading locations...

Similar Trials